The research findings primarily focus on individuals with a sleep disorder but may have broader implications. A recent study ...

The mysterious death of actor Gene Hackman and his wife rattled and baffled the Santa Fe community. New details emerge about the couple's final hours.

AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...

CV risk factors don’t just impact heart health, but also affect other organs, including the brain, say experts.

Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter with an ALS advocate, Ben-Noon assembled a team of top scientists to develop ...

Since Alzheimer’s advanced stage has no cure right now, the entire focus of Zentara is on prevention. For this purpose, it has identified two goals: make early Alzheimer’s diagnosis cheaper and give ...

Alzheimer’s research requires studies that can last for decades, said Dr. Thomas Grabowski, the center’s director and a professor of radiology and neurology at the UW School of Medicine. Those studies ...

Leerink Partners 2025 Global Healthcare Conference Call March 12, 2025 11:20 AM ETCompany ParticipantsRoland Chen ...

Chicago area scientists have identified the genes that drive the process of Alzheimer’s disease and are working to make the drug Lecanemab even better by identifying which genes are active ...

Adults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according ...

While researchers continue to work on a full cure for Alzheimer's disease, they're finding treatments that can help manage ...

Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...